| Shared signatures between rheumatoid arthritis, systemic lupus erythematosus and Sjögren’s syndrome uncovered through gene expression meta-analysis D Toro-Domínguez, P Carmona-Sáez, ME Alarcón-Riquelme Arthritis research & therapy 16 (6), 489, 2014 | 31 | 2014 |
| MetaGenyo: a web tool for meta-analysis of genetic association studies J Martorell-Marugan, D Toro-Dominguez, ME Alarcon-Riquelme, ... BMC bioinformatics 18 (1), 563, 2017 | 13 | 2017 |
| Stratification of Systemic Lupus Erythematosus Patients Into Three Groups of Disease Activity Progression According to Longitudinal Gene Expression D Toro‐Domínguez, J Martorell‐Marugán, D Goldman, M Petri, ... Arthritis & Rheumatology, 2018 | 12 | 2018 |
| ImaGEO: Integrative Gene Expression Meta-Analysis from GEO database D Toro-Domínguez, J Martorell-Marugán, R López-Dominguez, ... Bioinformatics, 2018 | 11 | 2018 |
| Support for phosphoinositol 3 kinase and mTOR inhibitors as treatment for lupus using in-silico drug-repurposing analysis D Toro-Domínguez, P Carmona-Sáez, ME Alarcón-Riquelme Arthritis research & therapy 19 (1), 54, 2017 | 8 | 2017 |
| Metagene projection characterizes GEN2. 2 and CAL-1 as relevant human plasmacytoid dendritic cell models P Carmona-Sáez, N Varela, MJ Luque, D Toro-Domínguez, ... Bioinformatics 33 (23), 3691-3695, 2017 | 5 | 2017 |
| Longitudinal Stratification of Gene Expression Reveals Three SLE Groups of Disease Activity Progression D Toro‐Domínguez, J Martorell‐Marugán, D Goldman, M Petri, ... Arthritis & Rheumatology, 2018 | 2 | 2018 |
| SUPPORT FOR PHOSPHOINOSITOL 3 KINASE INHIBITORS AS TREATMENT OF LUPUS USING IN SILICO DRUG REPURPOSING ANALYSIS D Toro Dominguez, P Carmona-Saez, ME Riquelme CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 34 (4), S24-S25, 2016 | | 2016 |
Pedro Carmona-SáezHead of Bioinformatics Unit, GENYOVerified email at genyo.es
